Similar drugsTo uncover
Dosage form: & nbsp
Gel for topical application.
Composition:
1 g of gel contains
Active substances:
lidocaine hydrochloride - 25 mg, neomycin sulfate - 5 mg, fluocinolone acetonide - 0.25 mg;
Excipients:
sodium carboxymethyl cellulose, sodium citrate, glycerin (glycerol), propylene glycol, methyl p-hydroxybenzoate, ethyl p-hydroxybenzoate, propyl p-hydroxybenzoate, sodium benzoate, purified water.

Description:Transparent, homogeneous, almost colorless gel.
Pharmacotherapeutic group:Antibiotic + glucocorticosteroid + local anesthetic
ATX: & nbsp
  • Other drugs for the treatment of urological diseases
  • Pharmacodynamics:
    Combined drug. Lidocaine hydrochloride has a local anesthetic effect. Neomycin sulfate - aminoglycoside antibiotic with a bactericidal action having a broad antibacterial spectrum against Gram-positive cocci, Gram negative rods and actinomycetes. Fluorocinol acetonide is a synthetic glucocorticosteroid that provides
    anti-inflammatory effect with topical application. Does not affect the antibacterial activity of neomycin and enhances the analgesic effect of lidocaine.
    Indications:
    - Diagnostic and medical procedures: cystoscopy, bladder catheterization, urethral enlargement, colposcopy, rectoscopy, colonoscopy, etc .;
    - Acute and chronic nonspecific inflammatory diseases of the lower urinary tract: acute cystitis, exacerbation of chronic cystitis, urethritis;
    - Infectious and inflammatory diseases of the rectum: hemorrhoids, acute anal fissure, crypts, anusitis, inflammatory skin changes with active fistulas of the rectum.
    Contraindications:Hypersensitivity to lidocaine (or other anesthetic agents of the amide series), neomycin, fluocinolone acetonide or to other components of the drug.
    Carefully:FROM caution apply in children, elderly patients and weakened patients.
    Pregnancy and lactation:The safety of the drug in pregnant women and during lactation has not been studied. Therefore, the use of Nefuana during pregnancy, especially in its early stages, as well as during breastfeeding, is not desirable or should be carefully justified.
    Dosing and Administration:
    Diagnostic and treatment procedures. Neufuan is squeezed out of the tube directly into the urethra by squeezing the tube and simultaneously massaging the posterior wall of the urethra.Then, a compressor is applied to the urethra, which is removed after 10 minutes, after which endourethral procedures are performed.
    To simplify the administration of the drug and relieve the pain that can occur when the metal part of the tube tip touches the pain zones, a plastic extension is attached to the tube, screwed onto the tube immediately before use. The drug is recommended to enter a few minutes before the start of diagnostic or therapeutic manipulation, as well as immediately after their end.
    The contents of one tube is enough to fill the entire urethra, however in some cases the dose can be varied depending on the degree and intensity of the lesion and the effect required.
    When carrying out endoscopic research in proctology (sigmoidoscopy, colonoscopy), the gel is inserted into the anal canal 10-15 minutes before the procedure and again immediately before its beginning.
    Infectious-inflammatory diseases of the lower parts of the urinary tract. Neutral is injected into the urethra once or twice a day for 5-10 days.
    Infectious and inflammatory diseases of the rectum.The gel is applied to the affected surface of the skin and mucous membrane and is injected into the anal canal using an extension (after evacuation of the intestine and hygienic procedures) 3 times a day for 10-14 days.
    Side effects:Allergic reactions, skin itching, burning sensation, skin hyperemia.
    Special instructions:
    Efficacy and safety Nefuana, like any other local anesthetic, depends on the correct dosage and techniques of its use.
    To prevent side effects, it is necessary to strive to apply the minimum required amount of the drug, which is sufficient to achieve the desired effect. For a complete anesthesia of the urethra, when carrying out any instrumental interventions, it is usually sufficient to have one Nefuana tube.
    The risk of side effects increases with very long or continuous use of the drug, the use of large doses or in the presence of extensive lesions of the skin and mucous membranes.

    Effect on the ability to drive transp. cf. and fur:The effect on the ability to drive vehicles and mechanisms is not established.
    Form release / dosage:Gel for topical application.
    Packaging:Aluminum tubes 10 g each, a plastic urethral extension is added to each tube. The tube together with the urethral extension and the instruction for use is embedded in a cardboard box.
    Storage conditions:At a temperature of 8 to 30 ° C, in a place protected from light and inaccessible to children.
    Shelf life:2 years. Do not use after the expiry date printed on the package.
    Terms of leave from pharmacies:Without recipe
    Registration number:П N015877 / 01
    Date of registration:02.12.2009
    The owner of the registration certificate:L. Molteni and K. dei Fratelli Alitti Soetica di Ezerchicio SpAL. Molteni and K. dei Fratelli Alitti Soetica di Ezerchicio SpA Italy
    Manufacturer: & nbsp
    Representation: & nbspPolarStar PharmaPolarStar Pharma
    Information update date: & nbsp03.03.2016
    Illustrated instructions
      Instructions
      Up